These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 14692852)

  • 21. Stability of unusual verbalizations on the Rorschach for outpatients with schizophrenia.
    Adair HE; Wagner EE
    J Clin Psychol; 1992 Mar; 48(2):250-6. PubMed ID: 1573029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When Homer nods: an examination of some systematic errors in Rorschach scholarship.
    Masling J
    J Pers Assess; 2006 Aug; 87(1):62-73. PubMed ID: 16856787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive validity of the Rorschach Prognostic Rating Scale with schizophrenic patients.
    Newmark CS; Konanc JT; Simpson M; Boren RB; Prillaman K
    J Nerv Ment Dis; 1979 Mar; 167(3):135-43. PubMed ID: 438781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A consideration of challenges to psychological assessment instruments used in forensic settings: Rorschach as exemplar.
    Hilsenroth MJ; Stricker G
    J Pers Assess; 2004 Oct; 83(2):141-52. PubMed ID: 15456650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing the science of psychological assessment: the Rorschach Inkblot Method as exemplar.
    Weiner IB
    Psychol Assess; 2001 Dec; 13(4):423-32. PubMed ID: 11793888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Exner Rorschach: an analysis of its clinical validity.
    Vincent KR; Harman MJ
    J Clin Psychol; 1991 Jul; 47(4):596-9. PubMed ID: 1939707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation between social functioning and neurocognitive test results using the Optional Thinking Test in schizophrenia.
    Chino B; Mizuno M; Nemoto T; Yamashita C; Kashima H
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):63-9. PubMed ID: 16472360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing disturbed thinking and cognition using the Ego Impairment Index in older schizophrenia patients: paranoid vs. nonparanoid distinction.
    Auslander LA; Perry W; Jeste DV
    Schizophr Res; 2002 Jan; 53(3):199-207. PubMed ID: 11738533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The challenges of ecological validity in the measurement of social perception in schizophrenia.
    Vaskinn A; Sergi MJ; Green MF
    J Nerv Ment Dis; 2009 Sep; 197(9):700-2. PubMed ID: 19752651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whither the Rorschach? An analysis of the evidence.
    Hunsley J; Bailey JM
    Psychol Assess; 2001 Dec; 13(4):472-85. PubMed ID: 11793892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weiner's Psychodiagnosis in schizophrenia: a classic revisited.
    Perry W
    J Pers Assess; 1994 Feb; 62(1):180-6. PubMed ID: 8138884
    [No Abstract]   [Full Text] [Related]  

  • 33. The Rorschach Ego Impairment Index: prediction of treatment outcome in a child psychiatric population.
    Stokes JM; Pogge DL; Powell-Lunder J; Ward AW; Bilginer L; DeLuca VA
    J Pers Assess; 2003 Aug; 81(1):11-9. PubMed ID: 12842799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A further comment on Weiner's Rorschach color indicators.
    Orme JE
    J Clin Psychol; 1966 Apr; 22(2):223. PubMed ID: 5937050
    [No Abstract]   [Full Text] [Related]  

  • 35. Response frequency and Exner's active-passive ratio as Rorschach indicators of flexibility.
    McCloskey L
    Percept Mot Skills; 2010 Oct; 111(2):559-75. PubMed ID: 21162456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roots of the Rorschach controversy.
    Garb HN; Wood JM; Lilienfeld SO; Nezworski MT
    Clin Psychol Rev; 2005 Jan; 25(1):97-118. PubMed ID: 15596082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rorschach indices for discriminating between two schizophrenic syndromes.
    Di Nuovo S; Laicardi C; Tobino C
    Percept Mot Skills; 1988 Oct; 67(2):399-406. PubMed ID: 3217185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the Rorschach in planning psychotherapy.
    Frank G
    Psychol Rep; 1995 Oct; 77(2):607-10. PubMed ID: 8559887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A methodology for the use of the Rorschach in clinical research.
    Blatt SJ; Berman WH
    J Pers Assess; 1984 Jun; 48(3):226-39. PubMed ID: 6747802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the prediction of aggressive behavior from the Rorschach.
    Frank G
    Psychol Rep; 1994 Aug; 75(1 Pt 1):183-91. PubMed ID: 7984721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.